secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001683168-24-005938
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals enters 5-year distribution agreement with Medline for wound care products
--------------------------------------------------------------------------------

- Distribution agreement effective August 19, 2024, covers wound cleansers and other products in the United States.
- Initial term of 5 years with automatic one-year renewal periods unless either party provides non-renewal notice.
- Medline to submit orders via EDI; Supplier must maintain a specified fill rate and lead time with performance-related discounts.
- Termination rights for material breach (30-day cure period) or bankruptcy; Medline can also terminate for quality or fill rate failures.
- Agreement includes standard confidentiality, indemnification, and recall cooperation provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824005938/0001683168-24-005938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824005938/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-005938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer